Bora CDMO Bora CDMO

X

Find Radio Compass News for Aliskiren

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - EQ 150MG BASE
  • TABLET;ORAL - EQ 300MG BASE
  • TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

https://www.nytimes.com/2020/07/01/business/Novartis-kickbacks-diabetes-heart-drugs.html

Neil Vigdor NYTIMES
02 Jul 2020

http://www.pharmatimes.com/news/nhs_england_scraps_7_more_drugs_on_prescription_1293506

Anna Smith PHARMATIMES
09 Jul 2019

https://www.fiercepharma.com/pharma/big-pharma-hits-3b-payments-to-doctors-and-teaching-hospitals-cms

Kyle Blankenship FIERCE PHARMA
02 Jul 2019

https://www.fiercepharma.com/pharma/court-document-filed-error-reveals-novartis-kickback-suit-settlement-talks-report

Angus Liu FIERCE PHARMA
12 Jun 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205769

FDA
06 Mar 2019

https://www.ema.europa.eu/en/aliskiren-product-specific-bioequivalence-guidance

EMA
13 Dec 2018

https://www.ema.europa.eu/documents/product-information/rasilez-hct-epar-product-information_en.pdf

EMA
09 Oct 2018

https://www.fiercepharma.com/legal/kickbacks-evidence-against-novartis-wide-ranging-and-comprehensive-feds-say

Eric Sagonowsky FIERCEPHARMA
21 Mar 2018

https://www.biospace.com/article/releases/noden-pharma-announces-fda-approval-of-tekturna-aliskiren-oral-pellets-for-the-treatment-of-hypertension-in-adults-and-children-6-years-of-age-and-older/

BIOSPACE
15 Nov 2017

http://www.prnewswire.com/news-releases/noden-pharma-notified-of-anda-filing-for-tekturna-300468350.html

PR NEWSWIRE
05 Jun 2017

http://www.biospace.com/News/new-fda-report-cites-22-drugs-that-passed-phase-ii/444652/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

Mark Terry BIOSPACE
21 Jan 2017

http://www.financialexpress.com/article/industry/companies/novartis-refused-patent-for-anti-hypertension-drug-combination/231853/

Sajan C Kumar FINANCIAL EXPRESS
04 Apr 2016

http://www.prnewswire.co.uk/news-releases/apac-anti-hypertensive-therapy-market-hit-157-billion-in-2014-and-will-reach-199-billion-by-2021-says-gbi-research-563349381.html

PR NEWSWIRE
23 Dec 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY